151P Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer: Real-world analysis of chemotherapy use and impact on patient outcomes
Hiong, A., Dundee, P., Lawrentschuk, N., Lynam, J., Manohar, P., Sengupta, S., Weickhardt, A.J., Wong, S.S.L., Zhang, A.Y., Gibbs, P., Tran, B.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
246P Impact of renal impairment on first-line treatment in metastatic urothelial cancer
Wakeling, S., Inderjeeth, A., Weickhardt, A.J., Lynam, J., Gibbs, P., O'Haire, S., Zlatic, K., Wong, S.S.L., Sengupta, S., Manohar, P., Zhang, A., Wong, L-M., Tran, B., Conduit, C.J.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
165P Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer
Kelly, R., Wong, S.S.L., Shapiro, J., Weickhardt, A.J., Parente, P., Azad, A., Uccellini, A., Torres, J., Parnis, F., Kwan, E., Brown, S., Steer, C., Warren, M., Gibbs, P., Anton, A., Tran, B.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
1893P Immune-related adverse events from contemporary first-line combination therapies in metastatic renal cell carcinoma: Results from the IMDC
Navani, V., Lemelin, A., Powles, T.B., Liow, E.C.H., Wong, S.S.L., Meza, L.A., Ebrahimi, H., Saliby, R.M., Saad, E., Yuasa, T., Wood, L.A., Kollmannsberger, C.K., Graham, J., North, S., Basappa, N.S., Donskov, F., Rodriguez, C. Suarez, Lalani, A-K., Choueiri, T.K., Heng, D.Y.C.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article